Navigation Links
Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
Date:3/27/2013

lagolix Phase III clinical trials will fail to demonstrate that elagolix is safe and effective for the treatment of endometriosis; risk associated with the Company's dependence on corporate collaborators for clinical development, commercial manufacturing and marketing and sales activities. With respect to its pipeline overall, the Company faces risk that it will be unable to raise additional funding required to complete development of all of its product candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for commercial manufacturing and marketing and sales activities; uncertainties relating to patent protection and intellectual property rights of third parties; risks and uncertainties relating to competitive products and technological changes that may limit demand for the Company's products; and the other risks described in the Company's report on Form 10-K for the year ended December 31, 2012. Neurocrine undertakes no obligation to update the statements contained in this press release after the date hereof.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
2. Neurocrine Biosciences Reports First Quarter 2012 Results
3. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
4. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results
5. Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
7. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
8. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
9. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
10. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
11. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... -- This test can detect HIV infection if used 3 ... activities that can transfer body fluids from one person to ... needles. , An in-vitro diagnostic home-use test for ... works by looking for your body,s response to fighting the ... patients to learn their status in a single visit and ...
(Date:9/23/2014)... Research and Markets ( ... the  "Large Volume Wearable Injectors - 2nd ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... potential for the future. From the conventional ... the modern-day pre-filled syringes, pen-injectors, needle free ...
(Date:9/23/2014)... Rising health concerns, growing ... number of foreign and domestic players in the market ... India   The India Probiotic ... growth potential markets worldwide due to multiple factors such ... youth, changing food consumption patterns, increasing diabetic population, growing ...
Breaking Medicine Technology:WholeHealth Products announces the release of the FDA Cleared "HIV 1&2" Rapid Diagnostic Test for Professional and Retail 2Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 2India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 3
... Zimmer Holdings, Inc. (NYSE and SIX: ZMH) announced today that ... notes. The Company intends to use the ... of the outstanding borrowings under its credit facility and for ... Smith Incorporated, BNP Paribas Securities Corp. and RBS Securities Inc. ...
... 7, 2011 Vermillion, Inc. (NASDAQ: ... to present at the Stephens Fall Investment Conference. The conference ... New York City on November 15-16, 2011. Vermillion,s ... Wednesday, November 16, 2011 at 10:30 a.m. Eastern time, with ...
Cached Medicine Technology:Zimmer Holdings, Inc. Announces Offering of Senior Notes 2Vermillion to Present at Stephens Fall Investment Conference on November 16, 2011 2
(Date:9/23/2014)... The University of California, Davis, and Academia Sinica, ... China (Taiwan), have entered into a collaborative agreement ... program that couples cutting-edge research with opportunities to ... new companies. , The agreement was signed Sept.12 ... research at UC Davis and President Chi-Huey Wong ...
(Date:9/23/2014)... Dallas, TX (PRWEB) September 23, 2014 ... be taken before making a purchase. It’s difficult to ... and it’s easy for them to manipulate their customers ... mitigate this dilemma, but they tend to lack in ... Consumer Health Reports was founded to fix this ...
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- A test used ... geographic regions where certain lung infections are more common, a ... lung cancer is through the use of what,s known as ... imaging called FDG-PET is used, according to the study authors. ... do parts of the lungs that don,t have ...
(Date:9/23/2014)... DC (PRWEB) September 23, 2014 ... care? The National Quality Forum (NQF) released ... ( http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=77687 ), and an infographic ( http://bit.ly/1tX3lzA ... rising cost of healthcare, how patients define affordability, ... consumers to get the best possible healthcare at ...
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- The ... unapproved prescription drugs is growing, so doctors need ... Food and Drug Administration warned Tuesday. In ... so widespread that it has launched a program ... and administrators about proper drug purchasing procedures. The ...
Breaking Medicine News(10 mins):Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2Health News:Finding Affordable Care: Asking the Right Question is Key 2
... Laura Rogers, project director for the Pew Campaign ... following statement regarding the U.S. Food and Drug Administration,s ... of certain antibiotics in animal agriculture: , ... animal agriculture helps fuel the increase in antibiotic-resistant infections ...
... Insurance,Company (John Hancock) is reinforcing its commitment to ... requirements through an,affiliation with the ClearCert Clearinghouse. ... the year and effective January 1, 2009,will only ... Since beginning ...
... (The Dignity of a Person), an Instruction from the Vatican ... issues arising from biomedical research, provides guidance on how to ... age, said Cardinal Francis George of Chicago, president of the ... , "We welcome the Instruction as theologians, medical ...
... calcium and vitamin D in fight against osteoporosis, study finds ... of protein and cereal grains causes excess acid production in ... result in weakened bones. , However, a new study finds ... plenty of fruits and vegetables can strengthen bones. , The ...
... 12 Bionovo, Inc.,(Nasdaq: BNVI ) will ... agent BN108 at the 31st Annual San Antonio Breast ... Center, San Antonio TX,December 10-14, 2008. , ... the pathway for cancer cell,apoptosis (cell death) induced by ...
... Chronic Hepatitis and Liver Diseases for not only treatment & diagnosis ... , ... (PRWEB) December 12, 2008 -- This year, from ... held the 2008 International Symposium on Chronic Hepatitis and ...
Cached Medicine News:Health News:Statement From The Pew Charitable Trusts on the U.S. Food and Drug Administration's Reversal on Antibiotics Safeguards in Animal Farming 2Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 2Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 3Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 2Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 3Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 4Health News:Fruits and Veggies May Strengthen Bones 2Health News:Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium 2Health News:ITRI: Taiwan Focuses on C Liver Medic's R&D to Reach USD 6 Billion Potential Market in the World 2Health News:ITRI: Taiwan Focuses on C Liver Medic's R&D to Reach USD 6 Billion Potential Market in the World 3Health News:ITRI: Taiwan Focuses on C Liver Medic's R&D to Reach USD 6 Billion Potential Market in the World 4
... Sleepscan VISION ensures flexibility in system configuration ... VISION utilizes the powerful Netlink amplifier system, ... standard Ethernet connection. Only computer industry components ... Sleepscan VISION to take advantage of the ...
... From the Pioneer in Digital EEG ... Digital EEG system presents the latest ... the Ceegraph VISION. This innovative system ... remote communications and information management to ...
... MOBEE headboxes are ... XLTEK's line of portable ... with a robust new ... latest software, XLTEK's standard ...
... Slit Lamp is an all-in-one instrument for observation, ... also allows the SL 130 to be used ... the possibility of operating the slit projector in ... right hand. The instrument configuration allows you to ...
Medicine Products: